このエントリーをはてなブックマークに追加
ID 62029
フルテキストURL
著者
Muro, Misato Division of Hospital Dentistry, Okayama University Hospital
Soga, Yoshihiko Division of Hospital Dentistry, Okayama University Hospital ORCID Kaken ID publons researchmap
Higuchi, Tomoko Division of Hospital Dentistry, Okayama University Hospital
Kataoka, Kota Department of Preventive Dentistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Kaken ID
Ekuni, Daisuke Department of Preventive Dentistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences ORCID Kaken ID publons researchmap
Maeda, Yoshinobu Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Kaken ID researchmap
Morita, Manabu Department of Preventive Dentistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences ORCID Kaken ID publons researchmap
抄録
Severe oral mucositis occurs frequently in patients receiving hematopoietic stem cell transplantation (HCT). Oral mucosal bacteria can be associated with progression of oral mucositis, and systemic infection may occur via ulcerative oral mucositis. However, little information is available regarding the oral microbiota after HCT. Here, PCR-denaturing gradient gel electrophoresis (DGGE) was performed to characterize the oral mucosal microbiota, which can be affected by antibiotics, before and after HCT. Sixty reduced-intensity HCT patients were enrolled. Three patients with the least antibiotic use (quinolone prophylaxis and/or β-lactam monotherapy group) and three patients with the most antibiotic use (β-lactam-glycopeptide combination therapy group) were selected. Bacterial DNA samples obtained from the oral mucosa before and after HCT were subjected to PCR-DGGE. The trajectory of oral mucositis was evaluated. The oral mucosal microbiota in the β-lactam-glycopeptide combination therapy group was different from that in the quinolone prophylaxis and/or β-lactam monotherapy group, and Staphylococcus spp. and Enterococcus spp. were identified. Lautropia mirabilis was dominant in one patient. Ulcerative oral mucositis was observed only in the β-lactam-glycopeptide combination therapy group. In conclusion, especially with the use of strong antibiotics, such as glycopeptides, the oral mucosal microbiota differed completely from that under normal conditions, and consisted of Staphylococcus spp., Enterococcus spp., and unexpectedly L. mirabilis. The normal oral microbiota consists not only of bacteria, but these unexpected bacteria could be involved in the pathophysiology as well as systemic infection via oral mucositis. Our results can be used as the basis for future studies in larger patient populations.
キーワード
hematopoietic stem cell transplantation
oral mucositis
microbiota
antibiotics
PCR-denaturing gradient gel electrophoresis
備考
This is a post-peer-review, pre-copyedit version of an article published in Folia Microbiologica. The final authenticated version is available online at: http://dx.doi.org/10.1007/s12223-018-0596-1.
発行日
2018-03-12
出版物タイトル
Folia Microbiologica
63巻
5号
出版者
Springer Science and Business Media LLC
開始ページ
587
終了ページ
597
ISSN
0015-5632
NCID
AA00648779
資料タイプ
学術雑誌論文
言語
英語
OAI-PMH Set
岡山大学
論文のバージョン
author
PubMed ID
NAID
DOI
Web of Science KeyUT
関連URL
isVersionOf https://doi.org/10.1007/s12223-018-0596-1
助成機関名
Japan Society for the Promotion of Science
Ministry of Education, Culture, Sports, Science and Technology
Ministry of Health, Labour and Welfare
助成番号
JP26462881